COVID-19 in newborns: could it alter key hormone pathways?

NCT ID NCT04952870

Recruiting now Knowledge-focused Sponsor: University Hospital, Lille Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study follows 180 infants who had COVID-19 around birth to see if the infection affects hormone levels and development. Researchers focus on a temporary hormone surge called minipuberty, which is important for growth. By measuring hormones and developmental milestones, they hope to understand long-term effects.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this study could reveal how COVID-19 around birth affects infant development, pointing to ways to monitor or support at-risk children.
What could go wrong: This is an observational study, not a treatment trial. It is exploratory and may not find clear links. Results may not apply to all infants.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NEURODEVELOPMENTAL DISORDERS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

disease neurodevelopmental disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

NEURODEVELOPMENTAL DISORDERS NEWBORN, INFANT, DISEASE

Contacts and locations

Locations

Hop Jeanne de Flandre Chu Lille
RECRUITING

Lille, 59037, France
Uri-National and Kapodistrian University of Athens
NOT_YET_RECRUITING

Athens, Greece

More trials for these conditions

Other studies related to the condition(s) this trial covers.